Toru Hachisuga

Dr. Toru Hachisuga


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
HHHiroshi Harada
Hiroshi Harada
THToru Hachisuga
Toru Hachisuga
YHYoshikazu Harada
Yoshikazu Harada
MSMami Shibahara
Mami Shibahara
MMMidori Murakami
Midori Murakami
KYKiyoshi Yoshino
Kiyoshi Yoshino
Background: Immunoreactive (IR) subtype is one of the subtypes of high-grade serous ovarian carcinoma (HGSOC) with intra-tumoral lymphocytic infiltration. A positive prognostic correlation between IR subtype and R0 + optimal surgery has been reported. This study investigates the prognostic significance of the tumor-infiltrating lymphocytes (TILs) in the suboptimal surgery group of HGSOCs. Methods: After reviewing 318 malignant ovarian tumors detected in our database between 2000 and 2017, 74 HGSOCs with supplemental p53 immunostaining were selected. Differences in progression-free survival (PFS) and overall survival (OS) between the 2 groups of the IR subtype and the other subtypes were investigated. Based on pathological findings, HGSOCs were divided into 2 groups: those with or without abundant TILs. Results: Abundant TILs were detected in 17 cases of HGSOC (22.9%). Clinicopathological characteristics including age, CA125, FIGO stage, and residual disease did not show significant differences between the 2 groups. Lymph node metastasis was more common in the IR subtype group (p=0.04). In the suboptimal surgery group, the 5-year PFS and OS (Kaplan-Meier estimates) in cases with (n=10) or without (n=21) abundant TILs were 10% and 0% (P=0.097) and 70% and 28.5% (P=0.012), respectively. The median time (range) to OS in cases with or without abundant TILs were 58 (34-81) months and 39 (22-55) months, respectively. Multivariate analysis in OS showed significant differences in TILs. Conclusions: Abundant intra-tumoral lymphocytic infiltration is an independent and favorable prognostic indicator for the suboptimal surgery group in HGSOCs, and is associated with treatment response via cancer immunity.